Paladin Labs Report issue

Contributed to NME For profit Phase 2 Phase 3 Phase 4
Founded: Montreal Quebec Canada (1983)
Status: Acquired by Endo Pharmaceuticals (2014) → now Bristol-Myers Squibb (2001)

Organization Overview

First Clinical Trial
2010
NCT01067443
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Paladin Laboratories Inc | Paladin Labs Inc.